Abstract: Embodiments of the present disclosure generally relate to devices, methods and systems for dispensing solid forms of an agent to a subject. In some embodiments an agent disclosed herein can include a pharmaceutical, biological or other solid agent for dispensing to a subject in need thereof. In certain embodiments, the present disclosure describes devices, methods and systems for biometric data acquisition and monitoring before, during, and/or after dispensing solid dosage forms of an agent to a subject. In some embodiments, these devices can be portable and/or handheld devices.

Abstract: Embodiments of the present invention relate generally to determining compliance and/or efficacy of a dosing regimen of a pharmaceutical or other monitored agent to a subject. In certain embodiments, the present disclosure provides devices and methods for biometric data acquisition and monitoring before, during, or after administration of a pharmaceutical or other monitored agent to a user. Other embodiments of the present invention improve patient outcomes by giving patients more control over the delivery of their medication and by providing physicians with meaningful and accurate biometric and diagnostic data during treatment.

Abstract: Embodiments of the present disclosure relate generally to devices and systems for administering pharmaceutical, biological or other monitored agents to a subject. In certain embodiments, the present disclosure provides devices, methods and systems for biometric and diagnostic data acquisition and patient monitoring before, during, and after administration of pharmaceutical, biological or other monitored agents. Embodiments of the present disclosure can improve health outcome of a subject, for example, by giving patients more control over the delivery of their medication and by providing healthcare professionals with meaningful and more accurate biometric and diagnostic data during treatment.

Abstract: Embodiments of the present disclosure relate generally to devices and systems for administering pharmaceutical, monitored and/or biological agents via nebulization to a subject. In certain embodiments, the present disclosure provides devices, methods and systems for biometric and diagnostic data acquisition and patient monitoring before, during, and after the nebulization and administration of pharmaceutical, monitored and/or biological agents to a subject. In yet other embodiments, devices, systems and methods disclosed herein provide for delivery of agents where patients have an increased level of control over the delivery of their medication and by providing healthcare providers with meaningful and accurate biometric and diagnostic data during treatment.

Abstract: Embodiments of the present invention relate generally to determining compliance and/or efficacy of a dosing regimen of a pharmaceutical or other monitored agent to a subject. In certain embodiments, the present disclosure provides devices and methods for biometric data acquisition and monitoring before, during, or after administration of a pharmaceutical or other monitored agent to a user. Other embodiments of the present invention improve patient outcomes by giving patients more control over the delivery of their medication and by providing physicians with meaningful and accurate biometric and diagnostic data during treatment.

Abstract: Embodiments of the present disclosure relate generally to devices and systems for administering pharmaceutical, biological or other monitored agents to a subject. In certain embodiments, the present disclosure provides devices, methods and systems for biometric and diagnostic data acquisition and patient monitoring before, during, and after administration of pharmaceutical, biological or other monitored agents. Embodiments of the present disclosure can improve health outcome of a subject, for example, by giving patients more control over the delivery of their medication and by providing healthcare professionals with meaningful and more accurate biometric and diagnostic data during treatment.

Abstract: Embodiments of the present disclosure generally relate to devices, methods and systems for dispensing solid forms of an agent to a subject. In some embodiments an agent disclosed herein can include a pharmaceutical, biological or other solid agent for dispensing to a subject in need thereof. In certain embodiments, the present disclosure describes devices, methods and systems for biometric data acquisition and monitoring before, during, and/or after dispensing solid dosage forms of an agent to a subject. In some embodiments, these devices can be portable and/or handheld devices.

Abstract: Embodiments of the present disclosure relate generally to devices and systems for administering pharmaceutical, monitored and/or biological agents via nebulization to a subject. In certain embodiments, the present disclosure provides devices, methods and systems for bio-metric and diagnostic data acquisition and patient monitoring before, during, and after the nebulization and administration of pharmaceutical, monitored and/or biological agents to a subject. In yet other embodiments, devices, systems and methods disclosed herein provide for delivery of agents where patients have an increased level of control over the delivery of their medication and by providing healthcare providers with meaningful and accurate biomctric and diagnostic data during treatment.

Abstract: Embodiments of the present disclosure relate generally to devices and systems for administering pharmaceutical, monitored and/or biological agents via nebulization to a subject. In certain embodiments, the present disclosure provides devices, methods and systems for biometric and diagnostic data acquisition and patient monitoring before, during, and after the nebulization and administration of pharmaceutical, monitored and/or biological agents to a subject. In yet other embodiments, devices, systems and methods disclosed herein provide for delivery of agents where patients have an increased level of control over the delivery of their medication and by providing healthcare providers with meaningful and accurate biometric and diagnostic data during treatment.

Abstract: Embodiments of the present disclosure generally relate to devices, methods and systems for dispensing solid forms of an agent to a subject. In some embodiments an agent disclosed herein can include a pharmaceutical, biological or other solid agent for dispensing to a subject in need thereof. In certain embodiments, the present disclosure describes devices, methods and systems for biometric data acquisition and monitoring before, during, and/or after dispensing solid dosage forms of an agent to a subject. In some embodiments, these devices can be portable and/or handheld devices.

Abstract: Embodiments of the present disclosure relate generally to devices and systems for administering pharmaceutical, biological or other monitored agents to a subject. In certain embodiments, the present disclosure provides devices, methods and systems for biometric and diagnostic data acquisition and patient monitoring before, during, and after administration of pharmaceutical, biological or other monitored agents. Embodiments of the present disclosure can improve health outcome of a subject, for example, by giving patients more control over the delivery of their medication and by providing healthcare professionals with meaningful and more accurate biometric and diagnostic data during treatment.

Abstract: Embodiments of the present invention relate generally to determining compliance and/or efficacy of a dosing regimen of a pharmaceutical or other monitored agent to a subject. In certain embodiments, the present disclosure provides devices and methods for biometric data acquisition and monitoring before, during, or after administration of a pharmaceutical or other monitored agent to a user. Other embodiments of the present invention improve patient outcomes by giving patients more control over the delivery of their medication and by providing physicians with meaningful and accurate biometric and diagnostic data during treatment.

Abstract: This disclosure describes a method and apparatus for agglomerating stover to produce a liquid absorbing particle. The method comprises providing stover particles coated with a first binder component and then rolling the stover particles coated with the first binder component on a rotating surface. The rotating surface is inclined sufficiently to aid in the rolling of the stover particles. A second liquid binder component that readily chemically crosslinks with the first binder component is applied to the first binder component to produce a web that the stover particles adhere to. The web in combination with the inclined rotating surface rolls the stover particles thereby forming an agglomerated stover particle that will be suitable for absorbing liquids. Agglomerated stover particles are also described.

Abstract: This disclosure describes a method and apparatus for agglomerating stover to produce a liquid absorbing particle. The method comprises providing stover particles coated with a first binder component and then rolling the stover particles coated with the first binder component on a rotating surface. The rotating surface is inclined sufficiently to aid in the rolling of the stover particles. A second liquid binder component that readily chemically crosslinks with the first binder component is applied to the first binder component to produce a web that the stover particles adhere to. The web in combination with the inclined rotating surface rolls the stover particles thereby forming an agglomerated stover particle that will be suitable for absorbing liquids. Agglomerated stover particles are also described.